For instance, Listeria monocytogenes and F. nucleatum can activate RTKs like ErbB2, ErbB3, and EGFR, promoting tumor growth and resistance to RTK-targeted therapies in CRC. This evidence concerns the gene EGFR and colorectal carcinoma.